As an FDA-approved GLP-1 receptor agonist, semaglutide has significantly impacted the lives of many adults seeking long-term weight loss
Bruni, A., Gala-Lopez, B., Pepper, A
Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice
El Miedany Y, Abu-Zaid MH, El Gaafary M, El Naby MMH, Fathi N, Saber HG, Hassan W, Eissa M, Mohannad N, Khaled H, Mortada M, Nasef SI, Galal S, Ghaleb R, Tabra SAA, Mohamed SS, Medhat BM, Aly HM, Elolemy G, Gadallah N (2021) Egyptian consensus on treat-to-target approach for osteoporosis: a clinical practice guideline from the Egyptian academy of bone health and metabolic bone diseases